0001567619-20-011002.txt : 20200522
0001567619-20-011002.hdr.sgml : 20200522
20200522161551
ACCESSION NUMBER: 0001567619-20-011002
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200520
FILED AS OF DATE: 20200522
DATE AS OF CHANGE: 20200522
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: HULME GEOFFREY
CENTRAL INDEX KEY: 0001307047
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-30319
FILM NUMBER: 20906061
MAIL ADDRESS:
STREET 1: C/O PORTER ORLIN LLC
STREET 2: 666 FIFTH AVENUE, 34TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10103
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Innoviva, Inc.
CENTRAL INDEX KEY: 0001080014
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 943265960
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2000 SIERRA POINT PARKWAY
STREET 2: SUITE 500
CITY: BRISBANE
STATE: CA
ZIP: 94005
BUSINESS PHONE: 6502389600
MAIL ADDRESS:
STREET 1: 2000 SIERRA POINT PARKWAY
STREET 2: SUITE 500
CITY: BRISBANE
STATE: CA
ZIP: 94005
FORMER COMPANY:
FORMER CONFORMED NAME: THERAVANCE INC
DATE OF NAME CHANGE: 20020207
FORMER COMPANY:
FORMER CONFORMED NAME: ADVANCED MEDICINE INC
DATE OF NAME CHANGE: 20000302
4
1
doc1.xml
FORM 4
X0306
4
2020-05-20
1
0001080014
Innoviva, Inc.
INVA
0001307047
HULME GEOFFREY
1350 OLD BAYSHORE HIGHWAY, SUITE 400
BURLINGAME
CA
94010
0
1
0
0
Interim Principal Exec Officer
Common Stock
2020-05-20
4
F
0
339
14.10
D
46251
D
Common Stock
3500
I
See Footnote
The shares were withheld by the Issuer to satisfy income tax withholding obligations associated with the quarterly vesting of previously granted employee equity grants.
Includes 1,121 shares of common stock acquired under the Innoviva, Inc. Employee Stock Purchase Plan (ESPP) on May 15, 2020.
The reportable securities are owned directly by Steel Valley Capital LLC. The Reporting Person is the owner and manager of Steel Valley Capital LLC.
/s/ Geoffrey Hulme
2020-05-21